These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17430103)

  • 1. Pathway analysis for design of promiscuous drugs and selective drug mixtures.
    Sivachenko A; Kalinin A; Yuryev A
    Curr Drug Discov Technol; 2006 Dec; 3(4):269-77. PubMed ID: 17430103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
    Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
    Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leadlikeness and structural diversity of synthetic screening libraries.
    Verheij HJ
    Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive Workflow: novel software architecture for automating drug design.
    Cartmell J; Krstajic D; Leahy DE
    Curr Opin Drug Discov Devel; 2007 May; 10(3):347-52. PubMed ID: 17554862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we rationally design promiscuous drugs?
    Hopkins AL; Mason JS; Overington JP
    Curr Opin Struct Biol; 2006 Feb; 16(1):127-36. PubMed ID: 16442279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemogenomic approaches to rational drug design.
    Rognan D
    Br J Pharmacol; 2007 Sep; 152(1):38-52. PubMed ID: 17533416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance.
    Tóth G; Bowers SG; Truong AP; Probst G
    Curr Pharm Des; 2007; 13(34):3476-93. PubMed ID: 18220785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic library design.
    Huwe CM
    Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems biology, metabolic modelling and metabolomics in drug discovery and development.
    Kell DB
    Drug Discov Today; 2006 Dec; 11(23-24):1085-92. PubMed ID: 17129827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics approach to illustrate drug action mechanisms.
    Wang Y; Chiu JF; He QY
    Curr Drug Discov Technol; 2006 Sep; 3(3):199-209. PubMed ID: 17311565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The rational computer-aided design of new drugs: a review of the methods].
    Ivanov AS; Liul'kin IuA; Skvortsov VS; Rumiantsev AB
    Vestn Ross Akad Med Nauk; 1995; (12):51-6. PubMed ID: 8664605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery beyond the 'rule-of-five'.
    Zhang MQ; Wilkinson B
    Curr Opin Biotechnol; 2007 Dec; 18(6):478-88. PubMed ID: 18035532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically based modelling and prediction of drug interactions.
    Bois FY
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):154-61. PubMed ID: 19912164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in de novo design and scaffold hopping.
    Mauser H; Guba W
    Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-aided Drug Design and Drug Pharmacokinetic Prediction: A Mini-review.
    Tabeshpour J; Sahebkar A; Zirak MR; Zeinali M; Hashemzaei M; Rakhshani S; Rakhshani S
    Curr Pharm Des; 2018; 24(26):3014-3019. PubMed ID: 30179125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful drug discovery.
    Swinney DC
    Curr Top Med Chem; 2006; 6(5):403-4. PubMed ID: 16719799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.